TREVISAN, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 5.713
AS - Asia 2.522
EU - Europa 1.600
AF - Africa 583
SA - Sud America 489
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 26
Totale 10.993
Nazione #
US - Stati Uniti d'America 5.419
SG - Singapore 902
CN - Cina 576
IT - Italia 338
BR - Brasile 322
HK - Hong Kong 299
DE - Germania 184
VN - Vietnam 172
FI - Finlandia 123
PL - Polonia 100
SE - Svezia 98
FR - Francia 70
GB - Regno Unito 66
NL - Olanda 59
UA - Ucraina 58
RU - Federazione Russa 53
BJ - Benin 41
IN - India 40
AT - Austria 38
AR - Argentina 37
ZA - Sudafrica 35
CI - Costa d'Avorio 31
JP - Giappone 27
CA - Canada 26
BZ - Belize 24
EC - Ecuador 24
MX - Messico 24
IE - Irlanda 23
PT - Portogallo 23
PY - Paraguay 23
AE - Emirati Arabi Uniti 22
BA - Bosnia-Erzegovina 22
ES - Italia 22
MU - Mauritius 22
PK - Pakistan 22
TR - Turchia 22
CG - Congo 21
ID - Indonesia 21
AO - Angola 20
HU - Ungheria 20
IQ - Iraq 20
JO - Giordania 20
BD - Bangladesh 19
CZ - Repubblica Ceca 19
EG - Egitto 19
PS - Palestinian Territory 19
TT - Trinidad e Tobago 19
AL - Albania 18
MN - Mongolia 18
MY - Malesia 18
BE - Belgio 17
IR - Iran 17
KR - Corea 17
MG - Madagascar 17
AM - Armenia 16
BG - Bulgaria 16
DZ - Algeria 16
GH - Ghana 16
HR - Croazia 16
IS - Islanda 16
KE - Kenya 16
KG - Kirghizistan 16
ML - Mali 16
PH - Filippine 16
SA - Arabia Saudita 16
UY - Uruguay 16
VC - Saint Vincent e Grenadine 16
AD - Andorra 15
AU - Australia 15
BB - Barbados 15
CR - Costa Rica 15
CU - Cuba 15
GR - Grecia 15
HN - Honduras 15
NE - Niger 15
RS - Serbia 15
SN - Senegal 15
CH - Svizzera 14
CW - ???statistics.table.value.countryCode.CW??? 14
GT - Guatemala 14
IL - Israele 14
KZ - Kazakistan 14
LA - Repubblica Popolare Democratica del Laos 14
LV - Lettonia 14
LY - Libia 14
PA - Panama 14
PR - Porto Rico 14
SI - Slovenia 14
TJ - Tagikistan 14
TW - Taiwan 14
UG - Uganda 14
UZ - Uzbekistan 14
AZ - Azerbaigian 13
BW - Botswana 13
CO - Colombia 13
DK - Danimarca 13
LB - Libano 13
NZ - Nuova Zelanda 13
SK - Slovacchia (Repubblica Slovacca) 13
SY - Repubblica araba siriana 13
Totale 10.398
Città #
Fairfield 714
Ashburn 540
Woodbridge 501
Singapore 500
Chandler 410
Ann Arbor 343
Houston 317
Hong Kong 286
Wilmington 265
Cambridge 260
Seattle 234
Jacksonville 193
Beijing 173
Santa Clara 141
Boardman 118
Padova 114
Princeton 88
Bytom 70
Medford 60
Ho Chi Minh City 58
Helsinki 57
San Diego 57
Nanjing 56
Des Moines 55
Los Angeles 53
Roxbury 53
New York 51
Hanoi 37
Cotonou 36
Abidjan 31
Dong Ket 29
Guangzhou 29
Hefei 28
Munich 28
Chicago 27
Shenyang 27
Buffalo 23
Jinan 22
São Paulo 22
Amman 19
Belize City 19
Brooklyn 19
Dublin 18
Ulan Bator 18
Vienna 18
Nanchang 17
Warsaw 17
Johannesburg 16
Kingstown 16
Luanda 16
Nuremberg 16
Andorra la Vella 15
Antananarivo 15
Bamako 15
Bishkek 15
Dakar 15
Montevideo 15
Bridgetown 14
Hebei 14
Kampala 14
Tokyo 14
Baku 13
Falls Church 13
London 13
Milan 13
Nairobi 13
Panama City 13
Reykjavik 13
Yerevan 13
Athens 12
Conakry 12
Lusaka 12
Nassau 12
Norwalk 12
Noumea 12
Quito 12
Vientiane 12
Willemstad 12
Belo Horizonte 11
Dushanbe 11
Havana 11
Libreville 11
Niamey 11
Riga 11
San José 11
Tashkent 11
Accra 10
Asunción 10
Atlanta 10
Cape Town 10
Dearborn 10
Falkenstein 10
Frankfurt am Main 10
Harare 10
Jakarta 10
Jiaxing 10
Kigali 10
Kingston 10
Lisbon 10
Phnom Penh 10
Totale 6.901
Nome #
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo' 291
Changes in microRNA expression during disease progression in patients with chronic viral hepatitis 248
Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma 231
New Frontiers of Corneal Gene Therapy 226
Generation of a transgene-free human induced pluripotent stem cell line (UNIPDi001-A) from oral mucosa epithelial stem cells 211
HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys 207
The role of 21-hydroxylase in the pathogenesis of adrenal masses: Review of the literature and focus on our own experience 196
Adenoviral Vector-Mediated Gene Therapy for Adenocortical Carcinoma: Therapeutic Strategies and Safety Considerations 194
Phylogenetic characterization of Central/Southern European lineage 2 West Nile virus: Analysis of human outbreaks in Italy and Greece, 2013-2014 193
Characterization of Intra-Type Variants of Oncogenic Human Papillomaviruses by Next-Generation Deep Sequencing of the E6/E7 Region 193
Molecular requirements for self-interaction of the respiratory syncytial virus matrix protein in living mammalian cells 187
Human papillomavirus genotyping by 454 next generation sequencing technology. 186
Microfluidic-driven viral infection on cell cultures: Theoretical and experimental study 186
Modeling viral infectious diseases and development of antiviral therapies using human induced pluripotent stem cell-derived systems 181
Modelling neurotropic flavivirus infection in human induced pluripotent stem cell-derived systems 180
WU and KI Polyomaviruses in the Brains of HIV-Positive Patients With and Without Progressive Multifocal Leukoencephalopathy 177
Sixth European seminar in virology on virus–host interaction at single cell and organism level 172
Modelling West Nile Virus and Usutu Virus Pathogenicity in Human Neural Stem Cells 170
Microfluidic-driven viral infection on cell cultures: Theoretical and experimental study 167
Detection of polyomaviruses and herpesviruses in human adrenal tumors 165
Expression of aromatase and estrogen receptors in human adrenocortical tumors 165
West Nile virus infection in children 165
Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016 165
Generation of a transgene-free induced pluripotent stem cells line (UNIPDi002-A) from oral mucosa epithelial stem cells carrying the R304Q mutation in TP63 gene 163
Investigation on Human Adrenocortical Cell Response to Adenovirus and Adenoviral Vector Infection 160
Human KI and WU polyomavirus infection in immunocompromised subjects 157
Multifunctional, CD44v6-targeted ORMOSIL nanoparticles enhance drugs toxicity in cancer cells 156
Zika virus: From pathogenesis to disease control 155
Author Correction: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ (Nature, (2020), 584, 7821, (425-429), 10.1038/s41586-020-2488-1) 155
In silico approaches to Zika virus drug discovery 153
Induced pluripotent stem cells line (UNIPDi003-A) from a patient affected by EEC syndrome carrying the R279H mutation in TP63 gene 150
Human cytomegalovirus productively infects adrenocortical cells and induces an early cortisol response. 145
Oral mucosa-derived induced pluripotent stem cells from patients with ectrodactyly-ectodermal dysplasia-clefting syndrome 145
Reprogramming methods do not affect gene expression profile of human induced pluripotent stem cells 144
Primary bilateral adrenal B-cell lymphoma associated with EBV and JCV infection 143
Sars-cov-2 infection and disease modelling using stem cell technology and organoids 141
Human KI and WU polyomavirus infection in immunocompromised subjects 140
Draft Genome Sequences of Two Neisseria meningitidis Serogroup C Clinical Isolates 140
Investigation on the presence of polyomavirus, herpesvirus, and papillomavirus sequences in colorectal neoplasms and their association with cancer. 138
Genome editing technologies to fight infectious diseases 138
Modulation of human macrophages gene expression by OX2 protein of HHV8 132
Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma 131
A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models 131
Effects of interferon alpha on human hepatoma cell lines: DNA microarrays analysis and evaluation of cell proliferation 130
Analisi dell'effetto dell'infezione da citomegalovirus umano su cellule corticosurrenaliche 126
A novel CRISPR/Cas9-based iduronate-2-sulfatase (IDS) knockout human neuronal cell line reveals earliest pathological changes 125
Genome editing technologies to treat rare liver diseases 123
WU and KI Polyomaviruses Remain Orphans in Adults Reply 122
Evaluation of Replication Competent and Replication Incompetent Adenovirus-Mediated Toxicity in Human Adrenocortical Cells 119
Microfluidic-driven processes enhance control and optimization of adenoviral infection efficiency on cell cultures 117
Lentiviral vectors expressing chimeric NEDD4 ubiquitin ligases: An innovative approach for interfering with alpha-synuclein accumulation 115
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo 114
USP8 Down-Regulation Promotes Parkin-Independent Mitophagy in the Drosophila Brain and in Human Neurons 112
microRNA deregulation in HCV-associated hepatocellular carcinoma 110
Highthroughput microfluidic platform to enhance adenoviral vector-mediated transgene expression 109
Patterns of gene expression exhibited by the vOX2 (orfK14) protein of human herpesvirus 8 in PBMC-derived macrophages 108
Detection of polyomaviruses and herperviruses in human adrenal tumours 108
Characterization of human cytomegalovirus microRNA temporal expression profile and target prediction by dynamic expression analysis 107
Chimeric Nedd4 Ubiquitin Ligases as An Innovative Approach For Interfering With alpha-synuclein Accumulation in Parkinson’s Disease 106
Gene editing of patient-specific induced pluripotent stem cells for cell therapy of EEC-syndrome 102
Characterization of human cytomegalovirus microRNA US25 2 3p 101
High Risk human papillomavirus E6 induces expression of the histone demethylase KDM2B by repressing miR 146a in human keratinocytes 100
Expression of aromatase and estrogen receptors in human adrenocortical tumors. 99
Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors 97
MiRNA expression in HCV-related chronic liver disease correlates with disease severity. 97
Analysis of Human Cytomegalovirus-encoded microRNAs and cellular microRNAs during infection 96
Generation of lentiviral vectors expressing chimeric NEDD4 ubiquitin ligase specifically targeting alpha-synuclein: a tool for studying Parkinson’s disease pathogenesis and for the development of innovative therapeutic approaches 88
Human cytomegalovirus microRNAs target prediction by dynamic expression analysis. 86
Epidemiology, surveillance and diagnosis of Usutu virus infection in the EU/EEA, 2012 to 2021 84
Prediction of viral and host targets of human cytomegalovirus microRNAs. 84
Modulation of miR 34 miRNAs and related pluripotency genes in human keratinocytes by human papillomavirus oncogenes. 83
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients 78
Experimental evidence of a limited impact of new-generation perfluoroalkyl substance C6O4 on differentiating human dopaminergic neurons from induced pluripotent stem cells 77
Characterization of human cytomegalovirus microRNA temporal expression profile and target prediction by dynamic expression analysis. 75
The silent enemy: Celiac disease goes viral 71
Deep sequencing for accurate and highthroughput HPV genotyping in clinical samples. 68
Microfluidic-driven processes enhance control and optimization of adenoviral infection efficiency on cell cultures 61
Analysis of microrna expression in cytological cervical samples and correlation with HPV infection 59
Characterization of human cytomegalovirus microRNA US25-2-3p. 58
Morphologic and molecular evidence of viral infection in human brainstem. 51
Generation of induced pluripotent stem cells by integrating and non integrating viral vectors: comparison of different reprogramming methods. 49
null 49
Human Cytomegalovirus Replicates in Adrenocortical Cells and Stimulates Steroid Hormone Production 44
null 41
Totale 11.122
Categoria #
all - tutte 34.922
article - articoli 28.568
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021697 0 0 0 0 66 56 46 82 136 110 114 87
2021/20221.015 14 162 120 49 55 77 58 74 52 35 102 217
2022/2023848 129 112 18 123 139 103 3 58 105 10 37 11
2023/2024503 17 61 60 51 57 65 48 18 13 14 38 61
2024/20251.982 6 153 76 61 250 57 91 212 156 92 317 511
2025/20263.411 382 593 892 1.144 400 0 0 0 0 0 0 0
Totale 11.122